Tainan, Taiwan

Chien-An Chu

This inventor holds 1 USPTO granted patent. Top assignee: National Cheng-Kung University. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chien-An Chu. Retrieved from https://idiyas.com/inventor/chien-an-chu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chien-An Chu: Innovator in Colorectal Cancer Prognosis

Introduction

Chien-An Chu is a prominent inventor based in Tainan, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of colorectal cancer. His innovative work focuses on developing methods for accurate prognosis, which can greatly enhance patient outcomes.

Latest Patents

Chien-An Chu holds a patent for a groundbreaking method titled "Biomarker for prognosis of colorectal cancer." This patent provides a method for the accurate and sensitive characterization and prognosis of colorectal cancer in a subject. The method involves obtaining cancer tissue from the subject and determining the expression level of a miRNA and a target gene of the miRNA. Additionally, the patent includes a kit designed for the prognosis of colorectal cancer in subjects who require it. He has 1 patent to his name.

Career Highlights

Chien-An Chu is affiliated with National Cheng-Kung University, where he continues to engage in research and development. His work is instrumental in advancing the understanding of colorectal cancer and improving diagnostic methods.

Collaborations

Chien-An Chu collaborates with esteemed colleagues, including Hsiao-Sheng Liu and Chung-Ta Lee. Their combined expertise contributes to the innovative research being conducted at their institution.

Conclusion

Chien-An Chu's contributions to colorectal cancer prognosis exemplify the impact of innovative research in medicine. His work not only enhances scientific understanding but also holds the potential to improve patient care significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…